Figure 1
Figure 1. Schematic diagram of strategies for mapping MLL fusion target genes. All 5 human cell lines (top left) are derived from acute leukemia patients and represent early progenitor cells of myeloid origin. MV4;11 (expressing MLL-AF4) and THP-1 (expressing MLL-AF9) have one rearranged MLL allele and one wild-type (WT) MLL allele. ML-2 cells possess 2 alleles of MLL-AF6 but no WT MLL allele. U937 and HL60 cells contain 2 copies of WT MLL. The inducible mouse cells express MLL-ENL in the presence of the inducer. The MLL-ENL fusion protein is inactivated on withdrawal of the inducer. Target genes of MLL wild-type and MLL fusion proteins were obtained from MLL binding analysis in both human leukemic cells and the mouse inducible system.

Schematic diagram of strategies for mapping MLL fusion target genes. All 5 human cell lines (top left) are derived from acute leukemia patients and represent early progenitor cells of myeloid origin. MV4;11 (expressing MLL-AF4) and THP-1 (expressing MLL-AF9) have one rearranged MLL allele and one wild-type (WT) MLL allele. ML-2 cells possess 2 alleles of MLL-AF6 but no WT MLL allele. U937 and HL60 cells contain 2 copies of WT MLL. The inducible mouse cells express MLL-ENL in the presence of the inducer. The MLL-ENL fusion protein is inactivated on withdrawal of the inducer. Target genes of MLL wild-type and MLL fusion proteins were obtained from MLL binding analysis in both human leukemic cells and the mouse inducible system.

Close Modal

or Create an Account

Close Modal
Close Modal